Andria

About Andria Day

This author has not yet filled in any details.
So far Andria Day has created 28 entries.

OncoCyte to Release Bladder Cancer Data at the 2016 American Society of Clinical Oncology Annual Meeting

Positive New Data to be Featured in a Poster Discussion
ALAMEDA, Calif., May 19, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT: OCX), a developer of novel, non-invasive tests for the early detection of cancer, released today the abstract of data from a bladder cancer study that will be presented as a poster and also […]

By |May 19th, 2016|Uncategorized|Comments Off on OncoCyte to Release Bladder Cancer Data at the 2016 American Society of Clinical Oncology Annual Meeting

OncoCyte Reports First Quarter 2016 Financial Results

Conference Call to Discuss the Results at 5 p.m. ET
ALAMEDA, Calif., May 18, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, today reported its financial results for the quarter ended March 31, 2016 along with an update on recent corporate […]

By |May 18th, 2016|Uncategorized|Comments Off on OncoCyte Reports First Quarter 2016 Financial Results

OncoCyte 1Q Conference Call

http://public.viavid.com/index.php?id=119474

May 18, 2016  5:00 PM ET

By |May 12th, 2016|Uncategorized|Comments Off on OncoCyte 1Q Conference Call

OncoCyte to Report First Quarter Financial Results on May 18, 2016

ALAMEDA, Calif., May 12, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that it will release its financial and operating results for the quarter ended March 31, 2016 on Wednesday, May 18, 2016 after the close of the […]

By |May 12th, 2016|Uncategorized|Comments Off on OncoCyte to Report First Quarter Financial Results on May 18, 2016

OncoCyte’s Bladder Cancer Abstract to be Featured in a Poster Discussion Session at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

Live Panel Discussion on June 6, 2016 at 4:45pm CTALAMEDA, Calif., April 21, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that its bladder cancer abstract has been selected for presentation in a poster session, including a live […]

By |April 21st, 2016|Uncategorized|Comments Off on OncoCyte’s Bladder Cancer Abstract to be Featured in a Poster Discussion Session at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

OncoCyte and The Wistar Institute Announce Positive Results in the Development of a Blood-based Lung Cancer Test

ALAMEDA, Calif., April 04, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, and The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, today announced positive research results for a lung cancer diagnostic test being developed […]

By |April 4th, 2016|Uncategorized|Comments Off on OncoCyte and The Wistar Institute Announce Positive Results in the Development of a Blood-based Lung Cancer Test

OncoCyte Corporation Reports Full Year 2015 Financial Results

ALAMEDA, Calif., March 30, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, reported its financial results for the year ended December 31, 2015.

“We made significant progress in 2015 on the road to commercialization of our potential molecular diagnostics products.  We […]

By |March 30th, 2016|Uncategorized|Comments Off on OncoCyte Corporation Reports Full Year 2015 Financial Results

OncoCyte Corporation to Present at the 2016 BIO CEO & Investor Conference

ALAMEDA, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that William Annett, Chief Executive Officer, is scheduled to present an overview of the company and its progress at The 18th Annual BIO CEO & Investor Conference […]

By |February 2nd, 2016|Uncategorized|Comments Off on OncoCyte Corporation to Present at the 2016 BIO CEO & Investor Conference

OncoCyte Corporation Initiates Trading on the NYSE MKT

OncoCyte Corporation Initiates Trading on the NYSE MKT.

By |January 4th, 2016|Uncategorized|Comments Off on OncoCyte Corporation Initiates Trading on the NYSE MKT

OncoCyte Form 10 12.29.15

Click the link to download the form:

OncoCyte Form 10 Amended 12 29 15.

By |December 29th, 2015|Uncategorized|Comments Off on OncoCyte Form 10 12.29.15